IC
MYGN icon

IEQ Capital’s Myriad Genetics MYGN Stock Holding History

IEQ Capital’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
254,869
+104,627
+70% +$475K 0.01% 951
2026
Q1 		$676K Sell
150,242
-77,763
-34% -$405K ﹤0.01% 1179
2025
Q4 		$1.4M Buy
228,005
+66,471
+41% +$482K ﹤0.01% 906
2025
Q3 		$1.17M Buy
161,534
+85,262
+112% +$506K ﹤0.01% 948
2025
Q2 		$405K Buy
76,272
+58,446
+328% +$345K ﹤0.01% 1260
2025
Q1 		$158K Buy
+17,826
New +$214K ﹤0.01% 1420

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IEQ Capital's MYGN Position: Q2 2026 in Review

IEQ Capital increased its Myriad Genetics (MYGN) stake by 70% in Q2 2026, buying an estimated $475K and bringing the position to 254,869 shares worth $1.46M. The position accounts for 0.01% of the portfolio, ranked #951.

IEQ Capital first reported a position in MYGN in Q1 2025 and has held it in 6 quarters since. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • IEQ Capital held 254,869 shares of Myriad Genetics worth $1.46M as of Q2 2026.
  • IEQ Capital bought 104,627 Myriad Genetics shares in Q2 2026, an estimated $475K.
  • Myriad Genetics made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #951 holding.
  • IEQ Capital first reported a position in Myriad Genetics in Q1 2025 and has held it in 6 quarters since.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.